Teratogenicity of Antiepileptic Drugs

Objective Antiepileptic drugs (AED) have chronic teratogenic effects, the most common of which are congenital heart disease, cleft lip/palate, urogenital and neural tube defects. The aim of our study is to examine teratogenic effects of AED and the correlation between these malformations and AED in single or multiple pregnancies. Methods This is a retrospective study of malformations in children born to mothers currently followed up by our outpatient clinics who used or discontinued AED during their pregnancy. Their children were then investigated using echocardiography, urinary ultrasound, cranial magnetic resonance image, and examined by geneticists and pediatric dentists. Results One hundred and seventeen children were included in the study. Ninety one of these children were exposed to AED during pregnancy. The most commonly used AED were valproic acid and carbamazepine in monotherapy. The percentage of major anomaly was 6.8% in all children. Dysmorphic features and dental anomalies were observed more in children exposed especially to valproic acid. There were 26 mothers with two and four mothers with three pregnancies from the same fathers. No correlation was found between the distribution of malformations in recurring pregnancies and AED usage. Conclusion Our study has the highest number of dysmorphism examined in literature, found in all the children exposed to valproic acid, which may account for the higher rate of facial dysmorphism and dental anomalies. On lower doses of valproic acid, major malformations are not seen, although the risk increases with polytherapy. Our data also indicate possible effects of genetic and environmental factors on malformations.

[1]  G. Koren,et al.  Dose-Dependent Risk of Malformations With Antiepileptic Drugs: An Analysis of Data From the EURAP Epilepsy and Pregnancy Registry , 2015, Therapeutic drug monitoring.

[2]  A. Dirican,et al.  Behavioral characteristics and cognitive development among school age children born to women with epilepsy , 2015, Neurological research.

[3]  V. Smith,et al.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism , 2014, Archives of Disease in Childhood: Education & Practice Edition.

[4]  Mogens Vestergaard,et al.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. , 2013, JAMA.

[5]  K. Meador,et al.  Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study , 2013, The Lancet Neurology.

[6]  B. Irwin,et al.  Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero , 2013, Epilepsia.

[7]  A. Roten,et al.  Teratogenesis in repeated pregnancies in antiepileptic drug‐treated women , 2013, Epilepsia.

[8]  T. Tomson,et al.  Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry , 2011, The Lancet Neurology.

[9]  K. Meador,et al.  Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. , 2011, Brain : a journal of neurology.

[10]  W. Hauser,et al.  Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes , 2009, Neurology.

[11]  W. Hauser,et al.  Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding , 2009, Neurology.

[12]  K. Meador.  Effects of in Utero Antiepileptic Drug Exposure , 2008, Epilepsy currents.

[13]  N. Namboodiri,et al.  Cardiac Malformations Are Increased in Infants of Mothers with Epilepsy , 2008, Pediatric Cardiology.

[14]  M. Eadie,et al.  Seizure control in antiepileptic drug‐treated pregnancy , 2008, Epilepsia.

[15]  M. Cunnington,et al.  Effect of Dose on the Frequency of Major Birth Defects Following Fetal Exposure to Lamotrigine Monotherapy in an International Observational Study , 2007, Epilepsia.

[16]  S. Eisenschenk.  Treatment With Oxcarbazepine During Pregnancy , 2006, The neurologist.

[17]  R. Kälviäinen,et al.  Community‐based, Prospective, Controlled Study of Obstetric and Neonatal Outcome of 179 Pregnancies in Women with Epilepsy , 2006, Epilepsia.

[18]  J. Clayton-Smith,et al.  Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[19]  B. Irwin,et al.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  M. Eadie,et al.  Maternal valproate dosage and foetal malformations , 2005, Acta neurologica Scandinavica.

[21]  A. Auvinen,et al.  Antiepileptic drug use of women with epilepsy and congenital malformations in offspring , 2005, Neurology.

[22]  G. Baker,et al.  Neuropsychological effects of exposure to anticonvulsant medication in utero , 2005, Neurology.

[23]  S. Endo,et al.  Statistics on Deliveries of Mothers with Epilepsy at Yokohama City University Hospital , 2004, Epilepsia.

[24]  P. Pennell.  Pregnancy in women who have epilepsy. , 2004, Neurologic clinics.

[25]  B. Källén,et al.  Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation‐wide, population‐based register study , 2004, Acta paediatrica.

[26]  M. Yerby.  Corrections to: Clinical Care of Pregnant Women with Epilepsy: Neural Tube Defects and Folic Acid Supplementation , 2003, Epilepsia.

[27]  J. Clayton-Smith,et al.  Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate , 2002, Seizure.

[28]  L. Holmes.  The teratogenicity of anticonvulsant drugs: a progress report , 2002, Journal of medical genetics.

[29]  M. Morrell.  Folic Acid and Epilepsy , 2002, Epilepsy currents.

[30]  M. Yerby.  The use of anticonvulsants during pregnancy. , 2001, Seminars in perinatology.

[31]  D. Walshaw,et al.  Population based, prospective study of the care of women with epilepsy in pregnancy , 2000, BMJ : British Medical Journal.

[32]  P. Turnpenny,et al.  A clinical study of 57 children with fetal anticonvulsant syndromes , 2000, Journal of medical genetics.

[33]  M. Alikaşifoğlu,et al.  Results of the Turkish congenital malformation survey. , 1999, The Turkish journal of pediatrics.

[34]  G. Avanzini,et al.  Congenital malformations due to antiepileptic drugs , 1999, Epilepsy Research.

[35]  A. Hofman,et al.  Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal Epilepsy , 1997, Epilepsia.

[36]  G. Koren,et al.  Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. , 1997, American journal of medical genetics.

[37]  A. Ornoy,et al.  Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. , 1996, Archives of disease in childhood.

[38]  E. Gaily,et al.  Minor anomalies in children of mothers with epilepsy. , 1992, Neurology.

[39]  G. Avanzini,et al.  Malformations in offspring of 305 epileptic women: a prospective study , 1992, Acta neurologica Scandinavica.

[40]  K. Jones,et al.  Pattern of malformations in the children of women treated with carbamazepine during pregnancy. , 1989, The New England journal of medicine.

[41]  E. Gaily,et al.  Intelligence of children of epileptic mothers. , 1988, The Journal of pediatrics.

[42]  J. I. P. James,et al.  Recognizable Patterns of Human Malformation. Genetic, Embryologic and Clinical Aspects , 1971 .

[43]  D. W. Smith,et al.  Recognizable patterns of human malformation: genetic, embryologic, and clinical aspects. , 1970, Major problems in clinical pediatrics.

[44]  Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Obstetrical complications and change in seizure frequency , 2022 .